Cite
The nonadherence and risk factors of eradication failure by sequential therapy as first‐line anti‐Helicobacter pylori treatment in real‐world clinical practice.
MLA
Lee, Chun‐Te, et al. “The Nonadherence and Risk Factors of Eradication Failure by Sequential Therapy as First‐line Anti‐Helicobacter Pylori Treatment in Real‐world Clinical Practice.” Helicobacter, vol. 29, no. 1, Jan. 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1111/hel.13033.
APA
Lee, C., Wu, C., Chang, W., Yang, E., Hsieh, M., Chen, W., Sheu, B., & Cheng, H. (2024). The nonadherence and risk factors of eradication failure by sequential therapy as first‐line anti‐Helicobacter pylori treatment in real‐world clinical practice. Helicobacter, 29(1), 1–9. https://doi.org/10.1111/hel.13033
Chicago
Lee, Chun‐Te, Chung‐Tai Wu, Wei‐Lun Chang, Er‐Hsiang Yang, Ming‐Tsung Hsieh, Wei‐Ying Chen, Bor‐Shyang Sheu, and Hsiu‐Chi Cheng. 2024. “The Nonadherence and Risk Factors of Eradication Failure by Sequential Therapy as First‐line Anti‐Helicobacter Pylori Treatment in Real‐world Clinical Practice.” Helicobacter 29 (1): 1–9. doi:10.1111/hel.13033.